|
1
|
Updated clinical classification of pulmonary hypertension.
|
J Am Coll Cardiol
|
2009
|
12.05
|
|
2
|
Clinical classification of pulmonary hypertension.
|
J Am Coll Cardiol
|
2004
|
5.87
|
|
3
|
Riociguat for the treatment of pulmonary arterial hypertension.
|
N Engl J Med
|
2013
|
5.60
|
|
4
|
Sitaxsentan therapy for pulmonary arterial hypertension.
|
Am J Respir Crit Care Med
|
2003
|
2.64
|
|
5
|
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan.
|
J Am Coll Cardiol
|
2006
|
2.42
|
|
6
|
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
|
Ann Rheum Dis
|
2007
|
1.72
|
|
7
|
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension.
|
Eur Respir J
|
2012
|
1.62
|
|
8
|
Pulmonary arterial hypertension: pathophysiology and anesthetic approach.
|
Anesthesiology
|
2003
|
1.42
|
|
9
|
Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
|
Can J Cardiol
|
2012
|
1.42
|
|
10
|
Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension.
|
Ann Intern Med
|
2015
|
1.42
|
|
11
|
Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials.
|
BMJ
|
2012
|
1.28
|
|
12
|
Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension.
|
Arthritis Rheum
|
2013
|
1.04
|
|
13
|
Pulmonary capillary hemangiomatosis: the puzzle takes shape.
|
Chest
|
2014
|
0.99
|
|
14
|
Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension.
|
Am J Cardiol
|
2011
|
0.97
|
|
15
|
Endothelin in coronary artery disease and myocardial infarction.
|
Cardiol Rev
|
2013
|
0.96
|
|
16
|
Bone morphogenic protein-9 stimulates endothelin-1 release from human pulmonary microvascular endothelial cells: a potential mechanism for elevated ET-1 levels in pulmonary arterial hypertension.
|
Microvasc Res
|
2010
|
0.95
|
|
17
|
Temporal trends and drug exposures in pulmonary hypertension: an American experience.
|
Am Heart J
|
2006
|
0.94
|
|
18
|
Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension.
|
Can J Cardiol
|
2012
|
0.93
|
|
19
|
Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival.
|
Lung
|
2012
|
0.89
|
|
20
|
Eisenmenger syndrome and atrial septal defect: nature or nurture?
|
Can J Cardiol
|
2006
|
0.86
|
|
21
|
The endothelin system in pulmonary hypertension.
|
Can J Physiol Pharmacol
|
2003
|
0.85
|
|
22
|
ALK2 and BMPR2 knockdown and endothelin-1 production by pulmonary microvascular endothelial cells.
|
Microvasc Res
|
2012
|
0.84
|
|
23
|
Effects of bone morphogenic proteins and transforming growth factor-beta on In-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells.
|
Vascul Pharmacol
|
2008
|
0.83
|
|
24
|
Depressive symptoms in relation to physical functioning in pulmonary hypertension.
|
J Psychosom Res
|
2008
|
0.82
|
|
25
|
Altitude-related hypoxia: risk assessment and management for passengers on commerical aircraft.
|
Aviat Space Environ Med
|
2003
|
0.82
|
|
26
|
Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
|
Am J Cardiol
|
2011
|
0.81
|
|
27
|
Vascular endothelium summary statement V: Pulmonary hypertension and acute lung injury: public health implications.
|
Vascul Pharmacol
|
2006
|
0.80
|
|
28
|
Matrix metalloproteinases in the urine of patients with pulmonary arterial hypertension.
|
Chest
|
2005
|
0.78
|
|
29
|
[Definitions and diagnosis of pulmonary hypertension].
|
Turk Kardiyol Dern Ars
|
2014
|
0.77
|
|
30
|
A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.
|
BMC Cardiovasc Disord
|
2012
|
0.76
|
|
31
|
Step climbing capacity in patients with pulmonary hypertension.
|
Clin Res Cardiol
|
2012
|
0.76
|
|
32
|
Systemic sclerosis and early-onset pulmonary hypertension.
|
Chest
|
2010
|
0.75
|
|
33
|
From the echo bed to the pulmonary vascular bed: dobutamine testing in the noninvasive laboratory.
|
Chest
|
2014
|
0.75
|
|
34
|
Clinical relevance of endothelin B-mediated vasoconstriction in lambs with increased pulmonary blood flow.
|
Circulation
|
2004
|
0.75
|
|
35
|
Anatomical considerations for the development of a new transcatheter aortopulmonary shunt device in patients with severe pulmonary arterial hypertension.
|
Pulm Circ
|
2013
|
0.75
|